Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
14.28
-0.34 (-2.33%)
At close: Nov 21, 2024, 4:00 PM
14.50
+0.22 (1.54%)
After-hours: Nov 21, 2024, 5:56 PM EST

Arcus Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
1,3071,4301,4972,8431,685463
Upgrade
Market Cap Growth
4.53%-4.52%-47.33%68.68%263.88%-3.26%
Upgrade
Enterprise Value
3266045682,367903272
Upgrade
Last Close Price
14.6219.1020.6840.4725.9610.10
Upgrade
PE Ratio
---57.00--
Upgrade
Forward PE
----12.60-
Upgrade
PS Ratio
4.7812.2213.377.4221.6130.88
Upgrade
PB Ratio
2.373.092.283.383.362.83
Upgrade
P/TBV Ratio
2.473.092.283.383.362.83
Upgrade
P/FCF Ratio
--3.47-15.61-
Upgrade
P/OCF Ratio
--3.42-15.18-
Upgrade
EV/Sales Ratio
1.245.165.076.1811.5818.15
Upgrade
EV/EBITDA Ratio
---40.82--
Upgrade
EV/EBIT Ratio
---43.84--
Upgrade
EV/FCF Ratio
--1.31-8.36-
Upgrade
Debt / Equity Ratio
0.140.260.180.140.03-
Upgrade
Debt / EBITDA Ratio
---1.80--
Upgrade
Debt / FCF Ratio
--0.28-0.14-
Upgrade
Asset Turnover
0.220.100.080.320.160.06
Upgrade
Quick Ratio
5.164.355.457.516.008.31
Upgrade
Current Ratio
5.244.525.537.606.058.49
Upgrade
Return on Equity (ROE)
-49.77%-54.87%-35.62%7.89%-36.93%-42.48%
Upgrade
Return on Assets (ROA)
-15.25%-17.42%-11.92%2.85%-15.89%-23.20%
Upgrade
Return on Capital (ROIC)
-28.92%-31.25%-20.16%4.57%-22.75%-27.81%
Upgrade
Earnings Yield
-20.60%-21.47%-17.83%1.86%-7.30%-18.29%
Upgrade
FCF Yield
-12.89%-23.08%28.85%-9.92%6.41%-16.28%
Upgrade
Buyback Yield / Dilution
-17.25%-2.78%2.70%-35.04%-25.04%-26.60%
Upgrade
Total Shareholder Return
-17.25%-2.78%2.70%-35.04%-25.04%-26.60%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.